Stryker Corp (SYK)
374.60  -0.46 (-0.12%)

Stryker Corporation is a leading medical technology company that specializes in designing, manufacturing, and marketing innovative products and services for healthcare professionals and patients. The company offers a diverse range of medical devices, including surgical equipment, orthopedic implants, neurotechnology, and surgery assistance products. Stryker focuses on advancing healthcare through cutting-edge technology and solutions that enhance patient care, improve surgical outcomes, and streamline hospital operations. With a commitment to innovation and quality, Stryker plays a pivotal role in the medical industry, helping healthcare providers deliver effective treatment and improve the quality of life for patients around the world.

SummaryNewsPress ReleasesChartHistorical
Previous Close375.06
Open375.62
Bid374.06
Ask393.00
Day's Range373.15 - 376.49
52 Week Range285.79 - 398.20
Volume755,826
Market Cap141.26B
PE Ratio (TTM)41.76
EPS (TTM)9.0
Dividend & Yield3.200 (0.85%)
1 Month Average Volume1,269,843

News & Press Releases

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Foreverfool.com
These companies have ingrained competitive advantages in an evergreen industry backed by decades of dividend growth.
Via The Motley Fool · December 15, 2024
PepsiCo To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Thursdaybenzinga.com
Via Benzinga · December 12, 2024
Stryker declares an $0.84 per share quarterly dividend
Portage, Michigan, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable January 31, 2025 to shareholders of record at the close of business on December 31, 2024, representing an increase of 5.0% versus the prior year and previous quarter. 
By Stryker Corporation · Via GlobeNewswire · December 10, 2024
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukosbenzinga.com
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via Benzinga · December 2, 2024
Cracking The Code: Understanding Analyst Reviews For Strykerbenzinga.com
Via Benzinga · December 2, 2024
Analyst Expectations For Stryker's Futurebenzinga.com
Via Benzinga · October 30, 2024
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · October 24, 2024
This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Mondaybenzinga.com
Via Benzinga · December 2, 2024
Based on good technical signals, STRYKER CORP is potentially setting up for a breakout.chartmill.com
STRYKER CORP (NYSE:SYK) Reveals Intriguing Technical Aspects. Here's What You Need to Know.
Via Chartmill · November 8, 2024
Jim Cramer Likes Cava Group, Calls This Utilities Stock 'Terrific'benzinga.com
On Oct. 29, Citigroup analyst Jon Tower maintained Cava Group with a Neutral and raised the price target from $115 to $140.
Via Benzinga · November 1, 2024
Tech Stocks Rise Ahead Of Key Earnings, Gold Smashes Records, Bitcoin Nears All-Time Highs: What's Driving Markets Tuesday?benzinga.com
Wall Street took a breather on Tuesday, with most major indices treading water, while tech stocks saw gains as investors braced for earnings reports from mega-cap companies.
Via Benzinga · October 29, 2024
Looking Into Stryker's Recent Short Interestbenzinga.com
Via Benzinga · October 24, 2024
The Latest Analyst Ratings For Strykerbenzinga.com
Via Benzinga · October 14, 2024
Stryker reports third quarter 2024 operating results
Portage, Michigan, Oct. 29, 2024 (GLOBE NEWSWIRE) -- reported operating results for the third quarter of 2024:
By Stryker Corporation · Via GlobeNewswire · October 29, 2024
Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon
Stryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy?
Via MarketBeat · October 10, 2024
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · October 8, 2024
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · October 1, 2024
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit
Via News Direct · October 1, 2024
Here's How Much You Would Have Made Owning Stryker Stock In The Last 15 Yearsbenzinga.com
Via Benzinga · September 10, 2024
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yetbenzinga.com
The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers and what could be ahead.
Via Benzinga · September 20, 2024
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · September 18, 2024
Stryker completes acquisition of care.ai
Portage, Michigan, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), announced that it has completed the previously announced acquisition of care.ai, a privately held company specializing in delivering AI-assisted virtual care workflows, smart room technology and ambient intelligence solutions.
By Stryker Corporation · Via GlobeNewswire · September 17, 2024
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.
Via MarketBeat · September 17, 2024
Stryker Unveils New Foot & Ankle Solutions With Truss Implants: Detailsbenzinga.com
Stryker Corporation announced new Foot & Ankle products from 4WEB Medical, with analysts maintaining positive ratings.
Via Benzinga · September 11, 2024
Stryker Expands Foot & Ankle Portfolio With Specialized Offerings Designed to Enhance Surgical Precision and Outcomes
Stryker (NYSE:SYK), a global leader in medical technologies, announced the addition of two new products to its Foot & Ankle portfolio – the Osteotomy Truss System™ (OTS) and Ankle Truss System™ (ATS), recently acquired from 4WEB Medical. The company will feature both the OTS and ATS, the newly acquired Artelon portfolio, and other products at the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting taking place in Vancouver, Canada from Sept. 11-14, 2024.
By Stryker · Via Business Wire · September 11, 2024